23 Jul, 2026
The global adherence packaging market size reached USD 1.13 billion in 2025 and is anticipated to grow from USD 1.21 billion in 2026 to USD 2.05 billion by 2034, expanding at a CAGR of 6.84% over the forecast period from 2026 to 2034.
Adherence packaging is mainly used in healthcare settings to do away with burdensome medication planners and schedule drug consumption the way patients do. To make taking their medication as directed by their doctor easier, the patient receives it throughout the day or as time passes. Unwell patients, such as those with diabetes or high blood pressure, continuously experience it. Patients with cardiac issues must follow their prescribed drug schedules to avoid relapses or hospital readmissions. Blister cards and multi-medication pouches typically contain sticky packaging. Each of these factors contributes to the expansion of the market for adhesive packaging.
The growing need to cut down on medication wastage has led to growth in the adherence packaging industry. Medication waste has adverse environmental effects and is expensive for the healthcare system. Therefore, preventing the drug from being underutilized along the pharmaceutical supply chain is an intriguing strategy to ensure long-term medicine supply and utilization. Manufacturers can support medications' long-term collecting and use by prolonging shelf life, selecting the most environmentally friendly storage solutions, and altering package size. Distributors are in charge of optimizing stock management procedures and enhancing shelf-life restrictions.
The efficacy of a treatment is greatly affected by the degree to which patients use it. When prescribed care is not given, it can have devastating effects on both the patient and the healthcare system. Serious health issues, even death, and increased medical costs are experienced by patients who do not take their medications as prescribed. Adherence is likely to be impacted by a variety of circumstances. Adherence barriers may arise from issues involving patients, healthcare professionals, and the healthcare system, as well as from interactions between them. A Truven Health Analytics-NPR Health Poll found that 67% of patients do not take their prescription as directed because it is so expensive, adding to a multibillion-dollar burden that is particularly challenging for population health management projects.
North America is the most significant contributor to revenues and is anticipated to expand at a CAGR of 5.70% during the projection period. One of the most critical regions in the world, North America, has a substantial percentage of the adherent packaging business owned by the United States. The nation's overabundance of minor and major retailers is to blame for the rise in demand. For instance, the company provides pouch packaging and blister packaging to retail pharmacies, hospitals, discharge patients, long-term care, assisted living, skilled nursing communities, physicians, accountable care organizations (ACOs), home health agencies, group homes, and correctional facilities. For instance, Parata's pharmacy automation solutions have been installed in more than 4,500 pharmacies across North America in a variety of settings.
Europe is anticipated to grow at a CAGR of 6.70% during the forecast period. There are currently companies offering controlled dose solutions around Europe that are committed to improving health outcomes through drug adherence. For instance, Jones Health Care Group provides a full range of adherence packaging to over 12,000 pharmacies in 20 countries. Additionally, qualified pharmacists collaborate directly with medical experts, groups, and institutions at Venalink teams (a Jones Healthcare Group Company), which has offices in the UK and Spain. Together, they create cutting-edge packaging, industry standards, and medication administration methods for the European and British markets. The market focuses on circular design concepts for products to sell more environmentally friendly packaging.
sales@straitsresearch.com